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Aims The increasing usage of antibiotics can cause resistance to the treatment of infections, which can caused by bacteria, e.g. Pseudomonas aeruginosa.The aim of this study was to trace the class I, II and III integrons in isolates of P. aeruginosa of nosocomial infection and determining the antibiotic resistance pattern of the bacteria. 
Instrument & Methods In this cross-sectional study, 100 Pseudomonas aeruginosa clinical isolates of infected wounds, bedsores, burns, urinary tract infections and respiratory tract infections were collected from patients of 3 Isfahan City hospitals, Iran (Al Zahra, Kashani, 
Shariati) in 2015.  After identification tests and antibiogram, integrons class I, II and III were detected by M-PCR method.Data analysis were performed in SPSS 16 software using Chi-square and Fisher exact tests and the relationship between the presence of class III, II, I was calculated by M-PCR test.
Findings All isolates had multiple antibiotic resistances. The highest antibiotic resistance 
was to Tetracycline (85%) and the lowest to Norfloxacin (12.5%). There were significant differences between class I and the two other classes of integrons (p=0.036). There was a 
statistically significant difference between the presence of blaTEM gene in Pseudomonas 
aeruginosa with other coding genes for antibiotic resistance (p=0.029).
Conclusion Pseudomonas aeruginosa isolates are multi-drug resistant and almost all isolates from clinical infections have class I, II and III Integrons.
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Introduction 
Pseudomonas aeruginosa is a non-
fermentative and gram-negative bacilli that 
causes nosocomial infection in the natural 
host [1]. Pseudomonas is found in large 
quantities in water, soil, plants and animals. 
This bacterium can live as normal flora on the 
skin, nose and respiratory systems of humans 
too [2]. Because the bacteria have low needs to 
grow, it remains in the environment and can 
be easily transmitted to susceptible patients 
and infect them [3].  
Pseudomonas has an outer membrane with 
low permeability. It also has multidrug 
discharger pumps, lactamase and the outer 
membrane purine degradation set that could 
be the important reason for resistance of 
these microorganisms to treatment [2]. Coding 
genes of antibiotic resistance are often 
transported by mobile genetic elements called 
integrons [1]. 
Integrons are mobile elements that can be 
placed in plasmids, chromosomes or even 
transposons. These elements are important in 
the development of multiple drug resistance 
in Pseudomonas. The overall structure of 
integrons, resistance genes are on determined 
gene cassettes. The transfer of resistance 
genes occur due to the connection of cassette 
in the integron set during specific 
recombination process [4]. At the end of the 3' 
and 5' integrons, 2 nucleotide sequences are 
protected. The role of these elements in the 
development of multiple resistance and 
resistance to a wide range of antibiotics, 
especially antibiotics used in hospitals, makes 
finding appropriate treatment and infection 
control tools difficult [4, 5].  
Given the important role of this bacterium in 
nosocomial infections and the role of integron 
gene cassettes based on the transfer of 
antibiotic resistance, the aim of this study was 
to trace the class I, II and III integrons in 
isolates of P. aeruginosa of nosocomial 
infection and determining the antibiotic 
resistance pattern of the bacteria. 
 
Instrument & Methods 
In this cross-sectional study, 100 
Pseudomonas aeruginosa clinical isolates of 
infected wounds (24 isolates), bedsores (18 
isolates), burns (38 isolates), urinary tract 
infections (12 isolates) and respiratory tract 
infections (8 isolates) were collected from 
patients of 3 Isfahan City hospitals, Iran (Al 
Zahra, Kashani, Shariati) in 2015. The patients 
were all infected after hospitalization at 
Orthopedics (21 cases), Internal ward (54 
cases), ICU (15 cases) and ICU special (10 
cases).  
Isolates have been transferred to a 
microbiology laboratory in Isfahan and were 
identified by biochemical tests [1]. Studied 
Isolates were re-identified after the 
restoration and re-cultivation on blood agar 
medium using biochemical tests such as Gram 
stain, catalase test and oxidase (Merck; 
Germany) [6, 7]. Bacteria grown in the TSB in 
1.5ml microtubes in 9000rpm were deposited 
for 3 minutes; DNA was extracted according to 
manufacturer's instructions (Fermentas, 
Germany). Agarose gel electrophoresis was 
used to assess the quality of extracted DNA 
from the analyzed samples. Bio photometer 
devices were used to quantify purified DNA 
and amount of DNA in the sample was 
determined by measuring DNA content of 
each sample at a light wave length of 280nm.  
P. aeruginosa isolates were also confirmed by 
PCR [8]. At all stages of PCR testing (Figure 1), 
the standard strains of P. aeruginosa (ATCC 
27853) was used as positive control [9].  
 
Figure 1) Sequencing primers [5, 10-12] related to 
detecting genes in Pseudomonas aeruginosa 
Gene Sequences (5’→3’) 
Length 
(bp) 
GyrA 
F: 5'-GTGTGCTTTATGCCATGAG-3' 
R: 5'-GGTTTCCTTTTCCAGGTC-3' 
287 
ParC 
F: 5'-CATCGTCTACGCCATGAG-3' 
R: 5'-AGCAGCACCTCGGAATAG-3' 
267 
Bla
TEM 
F: 5'-ATGAGTATTCAACATTTCCG-3' 
R: 5'-CTGACAGTTACCAATGCTTA-3' 
867 
Bla
SHV 
F: 5'-GGTTATGCGTTATATTCGCC-3' 
R: 5'-TTAGCGTTGCCAGTGCTC-3' 
867 
Bla
OXA 
F: 5'-ACACAATACATATCAACTTCGC-3' 
R: 5'-AGTGTGTTTAGAATGGTGATC-3' 
814 
Bla
CTX-M
F: 5'-ATGTGCAGYACCAGTAARGT-3' 
R: 5'-TGGGTRAARTARGTSACCAGA-3' 
593 
Bla
DHA 
F: 5'-CACACGGAAGGTTAATTCTGA-3' 
R: 5'-CGGTTARACGGCTGAACCTG-3' 
970 
Bla 
VEB 
F: 5'-CGACTTCCATTTCCCGATGC-3' 
R: 5'-GGACTCTGCAACAAATACGC-3' 
642 
IntI 
F: 5'-CAGTGGACATAAGCCTGTTC-3' 
R: 5'-CCCGAGGCATAGACTGTA-3' 
160 
IntII 
F: 5'-CACGGATATGCGACAAAAAG-3' 
R: 5'-GATGACAACGAGTGACGAAATG-3' 
787 
IntIII 
F: 5'-GCCTCCGGCAGCGACTTTCAG_3' 
R: 5'-ACGGATCTGCCAAACCTGACT-3' 
980 
 
Antibiogram was performed using disk 
diffusion method (Kirby Bauer) according to 
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CLSI tables. Isolates of P. aeruginosa were 
saved in BHI medium and then were prepared 
for a density equivalent to 0.5 McFarland 
dense to be presented to the Mueller Hinton 
medium in the presence of antimicrobial 
discs, e.g. Tetracycline (30mg/disc), 
Streptomycin (10mg/disc), Sulfamethoxazole 
(25mg/disc), Gentamicin (10mg/disc), 
Norfloxacin (5mg/disc), Cephalotin 
(3mg/disc), Ciprofloxacin (5g/disc), 
Trimethoprim (5mg/disc), and Ampicillin 
(10IU/disk) they were grown and after 24 
hours of incubation at 37°C, sensitivity or 
resistance of bacteria to different antibiotics 
were determined and measuring the diameter 
of growth inhibition around each disc. In this 
experiment, the standard strains of P. 
aeruginosa (ATCC 10145) were used as 
positive control in determination of antibiotic 
susceptibility of isolates [10-12].  
Data analysis were performed in SPSS 16 
software using Chi-square and Fisher exact 
tests and the relationship between the 
presence of class III, II, I was calculated by M-
PCR test. 
 
Findings 
58% of isolates was detected from women 
and 42% from men. All isolates had multiple 
antibiotic resistances. The highest antibiotic 
resistance was to Tetracycline (85%) and the 
lowest to Norfloxacin (12.5%); other 
resistances were to Streptomycin (25.6%), 
Sulfamethoxazole (18.3%), Gentamicin 
(65.1%), Cephalotin (42.2%), Ciprofloxacin 
(59.8%), Trimethoprim (17.2%), and 
Ampicillin (52.3%).  
 
Figure 2) Distribution of coding genes of antibiotic 
resistance in P. aeruginosa isolates from nosocomial 
infection 
Site  
Infected 
wounds 
Respiratory 
infections 
UTI BedsoreBurn Total
Number 24 7 13 18 38 100
BlaTEM 27 4 6 9 22 68
blaSHV 14 2 3 1 3 23
BlaOXA 1 2 1 3 3 10
BlaCTX-M 1 2 3 8 4 18
BlaDHA 1 2 1 2 4 10
blaVEB - - - 3 7 10
GyrA 2 3 - 3 4 12
parC 1 - - 2 2 5
 
The highest incidence of antibiotic resistance 
in Pseudomonas aeruginosa isolates was 
related to Integrons I with a frequency of 95% 
and the lowest was related to Integrons III 
with a frequency of 10%. There were 
significant differences between class I and the 
two other classes of integrons (p=0.036). 
Except the respiratory tract isolates, other 
integron classes were present in all studied 
isolates.  
There was a statistically significant difference 
between the presence of blaTEM gene in 
Pseudomonas aeruginosa with other coding 
genes for antibiotic resistance (p=0.029; 
Figure 2). 
 
Discussion  
Pseudomonas aeruginosa is an important 
pathogen that causes different ranges of 
human infections. It is especially resistant to 
many antibiotics and over time, it is somehow 
impossible to treat its infections. In this way, 
Pseudomonas aeruginosa is known as a multi-
drug resistance bacterium, especially in 
hospital acquired infection.  
In this study, we have 3 main components 
with the aim of analyses the frequency of 
isolates, antibiotic susceptibility patterns and 
distribution of class I, II and III integrons in P. 
aeruginosa isolates from nosocomial infection 
in Isfahan. Similar Studies were conducted by 
Ren et al. in 2012 in America [13], Cholly et al. 
in 2011 in France [14], Taccone et al. in 2012 in 
Brooklyn [15] and also in Iran, by Taghvaei et 
al. in 2013 in Arak [16].  
In our study, the most isolates were related to 
infected wounds (24%) and burns (38%). 
Zareei Yazdeli et al. have reported the highest 
number of infections with Pseudomonas 
aeruginosa at burns (43.8%) [5] and 
Shahcheraghi et al. have reported the 
frequency of Pseudomonas aeruginosa in the 
wound infections as 37% [17]. In Babay study 
in Saudi Arabia, the most isolates were 
separated from the wounds [18].  
In the first part of our study, the antibiotic 
pattern of Pseudomonas aeruginosa was 
examined and we were found that it has over 
50% resistance to more than 5 antibiotics. 
One of the main reasons for the emergence of 
this resistance is intractable consumption of 
some antibiotics including tetracycline. In 
Thailand, Poonsuk et al. have shown that an 
increase in resistance of Pseudomonas 
aeruginosa strains to Amikacin (92.1%), 
Ceftazidime (96%), Gentamicin (99%) and 
Ciprofloxacin (95%), while, the least 
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resistance were observed to Streptomycin 
(84%) and Tetracycline (58.8%) [19]. Fazeli et 
al. have shown that Pseudomonas aeruginosa 
isolates were resistant to Ciprofloxacin (29%) 
and Gentamicin (32.2%) [20]. Ciprofloxacin is 
one of the strongest medications available for 
the treatment of infections caused by 
Pseudomonas aeruginosa, particularly in 
treatment of urinary tract infections [21]. 
Resistance of Pseudomonas aeruginosa to 
Ciprofloxacin in Latin America have been 
reported 26.8% and in Europe 10-32% [22-25].  
The main 3 classes of integrons were detected 
with a frequency of 95% for I, 54% for II and 
10% for III. The prevalence of Integron I was 
reported by  Yousefi et al. as 56.3% [26], 
Fonseca et al. as 41.5% [27], Chen et al. as 38% 
[28] and GU et al. as 40.8% [29]. Shibata et al. 
have found Integron I the most common and 
Integron III was observed sporadically in 
Japan [30]. The prevalence of Integron II was 
reported 9% in Zanjan [2] and 5.3% in 
Malaysia [31]. 
There was no limitation on selecting samples 
or other part of study. In state hospitals, it is 
necessary to use management practices in 
order to optimize the use of antibiotics and 
the correct administration of antibiotics, 
preferably based on the results of antibiogram 
and tracking coding genes for antibiotic 
resistance. 
 
Conclusion 
Pseudomonas aeruginosa isolates are multi-
drug resistant and almost all isolates from 
clinical infections have class I, II and III 
Integrons.  
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